Jiho Yoo

Dr. Jiho Yoo


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2018 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
JYJiho Yoo
Jiho Yoo
EMEllene H. Mashalidis
Ellene H. Mashalidis
AKAlvin C. Y. Kuk
Alvin C. Y. Kuk
KYKazuki Yamamoto
Kazuki Yamamoto
BKBenjamin Kaeser
Benjamin Kaeser
SLSeok-Yong Lee
Seok-Yong Lee

3 August 2018 in Science
Verified
Journal Article
Closed access
PDF file
JYJiho Yoo
Jiho Yoo
MWMengyu Wu
Mengyu Wu
YYYing Yin
Ying Yin
MHMark A. Herzik
Mark A. Herzik
GLGabriel C. Lander
Gabriel C. Lander
SLSeok-Yong Lee
Seok-Yong Lee
A channel for calcium: Maintaining the correct balance of calcium concentrations between the cytosol and the mitochondria is essential for cellular physiology. A calcium-selective channel called the mitochondrial calcium uniporter (MCU) mediates calcium entry into mitochondria. Yoo et al. report the high-resolution structure of MCU from Neurospora crassa. The channel is formed by four MCU protomers with differing symmetry between the soluble and membrane domains. The structure, together with mutagenesis, suggests that two acidic rings inside the channel provide the selectivity for calcium. Science , this issue p. 506

10 June 2011 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
JYJu Ho Youn
Ju Ho Youn
MKMan Sup Kwak
Man Sup Kwak
JWJie Wu
Jie Wu
EKEun Sook Kim
Eun Sook Kim
YJYeounjung Ji
Yeounjung Ji
JSJeon‐Soo Shin
Jeon‐Soo Shin
Lipopolysaccharide (LPS) triggers deleterious systemic inflammatory responses when released into the circulation. LPS‐binding protein (LBP) in the serum plays an important role in modifying LPS toxicity by facilitating its interaction with LPS signaling receptors, which are expressed on the surface of LPS‐responsive cells. We have previously demonstrated that high mobility group box 1 (HMGB1) can bind to and transfer LPS, consequently increasing LPS‐induced TNF‐α production in human peripheral blood mononuclear cells (PBMCs). We report here on the identification of two LPS‐binding domains within HMGB1. Furthermore, using 12 synthetic HMGB1 peptides, we define the LPS‐binding regions within each domain. Among them, synthetic peptides HPep1 and HPep6, which are located in the A and B box domains of HMGB1, bind to the polysaccharide and lipid A moieties of LPS respectively. Both HPep1 and HPep6 peptides inhibited binding of LPS to LBP and HMGB1, LBP‐mediated LPS transfer to CD14, and cellular uptake of LPS in RAW264.7 cells. These peptides also inhibited LPS‐induced TNF‐α release in human PBMCs and induced lower levels of TNF‐α in the serum in a subclinical endotoxemia mouse model. These results indicate that HMGB1 has two LPS‐binding peptide regions that can be utilized to design anti‐sepsis or LPS‐neutralizing therapeutics.

1 September 2010 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
JUJi Won Um
Ji Won Um
EIEunju Im
Eunju Im
HLHyun Jung Lee
Hyun Jung Lee
BMBoram Min
Boram Min
LYLang Yoo
Lang Yoo
KCKwang Chul Chung
Kwang Chul Chung
Parkinson's disease (PD) is a common neurodegenerative disease that involves the deterioration of dopaminergic neurons in the substantia nigra pars compacta. Although the etiology of PD remains poorly understood, recent genetic, postmortem, and experimental evidence shows that abnormal protein accumulation and subsequent aggregate formation are prominent features of both sporadic and familial PD. While proteasome dysfunction is observed in PD, diverse mutations in theparkingene are linked to early-onset autosomal-recessive forms of familial PD. We demonstrate that parkin, an E3 ubiquitin ligase, activates the 26S proteasome in an E3 ligase activity-independent manner. Furthermore, an N-terminal ubiquitin-like domain within parkin is critical for the activation of the 26S proteasome through enhancing the interaction between 19S proteasomal subunits, whereas the PD-linked R42P mutant abolishes this action. The current findings point to a novel role for parkin for 26S proteasome assembly and suggest that parkin mutations contribute to the proteasomal dysfunction in PD.

16 May 2023 in Molecules and Cells
Verified
Journal Article
Open access
PDF file
DYDanbi Yoon
Danbi Yoon
JMJu Heun Moon
Ju Heun Moon
ACAnna Cho
Anna Cho
HBHyejoon Boo
Hyejoon Boo
JCJeong Seok Cha
Jeong Seok Cha
JYJiho Yoo
Jiho Yoo
Danbi Yoon, Ju Heun Moon, Anna Cho, Hyejoon Boo, Jeong Seok Cha*, Yoonji Lee*, and Jiho Yoo*. Mol. Cells 2023;46:337-44. https://doi.org/10.14348/molcells.2023.0001

20 February 2025 in Biomolecules
Verified
Journal Article
Open access
PDF file
HBHYE JOON BOO
HYE JOON BOO
DYDanbi Yoon
Danbi Yoon
YCYujeong Choi
Yujeong Choi
YKYounghyun Kim
Younghyun Kim
JCJeong Seok Cha
Jeong Seok Cha
JYJiho Yoo
Jiho Yoo
Quercetin, a prevalent plant flavonoid, demonstrates many biological functions through its interaction with distinct protein targets. Recent structural investigations of protein–quercetin complexes have elucidated the molecular mechanism behind these actions. This paper presents a thorough structural analysis of experimentally established protein–quercetin complex structures published to date. The structure of the protein–quercetin complex elucidates the molecular mechanism by which quercetin influences protein function. These structures illustrate how quercetin’s chemical characteristics facilitate diverse modes of action by enabling particular interactions with the target protein. This structural knowledge provides the molecular foundation for comprehending quercetin’s biological roles and indicates avenues for future structural investigations of flavonoid–protein complexes, especially those with ambiguous molecular processes.